Lord Ajay Kakkar is President of the Thrombosis Research Institute and Emeritus Professor of Surgery, University College London. He is Chairman of King’s Health Partners, the Office for Strategic Coordination of Health Research, the King’s Fund and UK Biobank. He completed his medical degree at King’s College London and received his PhD from Imperial College … Continued
Gloria Kayani is the Chief Executive Officer, with overall responsibility for creating, planning, implementing and integrating the strategic direction of CYTE. Ms Kayani has nearly 25 years of experience in Pharmaceutical R&D, Medical Affairs and academic research, responsible for the strategic oversight and delivery of projects spanning all phases of clinical research. This includes 15 … Continued
Frank Misselwitz is currently Chief Medical Officer at Actimed Therapeutics. He was the Corporate Vice President and Head of Cardiovascular Development at Bayer Pharma AG for 20 years. After receiving his MD and an MSc in medical biophysics in 1981, Dr Misselwitz earned his PhD in 1984. He has worked in the thrombosis field for … Continued
Annalisa Jenkins, M.B.B.S., F.R.C.P. serves as a member of the Perspectum Ltd. board of directors. Dr Jenkins also serves as Chairman of the court of the London School of Hygiene and Tropical Medicine. Dr Jenkins previously served as the Chief Executive Officer of PlaqueTec Ltd. and was previously the Chief Executive Officer and a member … Continued
